ORKAMBI

Swiss trademark · 669649 · Combined mark · In force

Register entry

Registration number
669649
Application number
63890/2014
Status
In force
Type
Combined mark
As registered
ORKAMBI ((fig.))
Filed
Nov 25, 2014
Registered
Feb 13, 2015
Published
Feb 13, 2015
Protected until
Nov 25, 2034
Colours claimed
Grün, hellblau.
Priority
19.09.2014 US
Remarks
Teilpriorität (Details siehe Aktenheft)
Language of procedure
German
Vienna classes
01.15.21, 26.01.01, 26.01.06, 26.01.24, 26.07.01
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate; pharmazeutische Präparate zur Behandlung von Hepatitis, zystischer Fibrose, Grippe, Krebs, viralen und bakteriellen Infektionen, entzündlicher Darmerkrankung, neurologischer Funktionsstörungen und Autoimmunerkrankung.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 17, 2024

    Renewed

    Published in Swissreg on 17.01.2024

  2. Feb 1, 2018

    Agent entered

    Representative
    FRORIEP AG, Bellerivestrasse 201, Postfach, 8034 Zürich → Walder Wyss AG, Seefeldstrasse 123, Postfach 1236, 8034 Zürich

    Published in Swissreg on 01.02.2018

  3. Aug 10, 2016

    Agent’s address changed

    Representative
    FRORIEP, Bellerivestrasse 201, 8034 Zürich → FRORIEP AG, Bellerivestrasse 201, Postfach, 8034 Zürich

    Published in Swissreg on 10.08.2016

  4. Feb 13, 2015

    Registered

    Published in Swissreg on 13.02.2015

Parties

Holder

Vertex Pharmaceuticals Incorporated

50 Northern Avenue, 02110 Boston MA, US

Agent

Walder Wyss AG

Seefeldstrasse 123 Postfach 1236, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.